NCT06563622

Brief Summary

Children can experience substantial pain after hip operations, causing agitation, depression, and sleep disruption, which can have a negative impact on their health. Opioids are associated with several serious side effects that limits its use as solo agents for pain management. Regional blocks such as caudal Block (CB) and pericapsular nerve group (PENG) block in adjuvant with general anaesthesia are alternative perioperative analgesic techniques that lead to lesser side effects, including motor weakness, postoperative nausea and vomiting with decreased opioid consumption.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 10, 2024

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

August 13, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 21, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2025

Completed
Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

8 months

First QC Date

August 13, 2024

Last Update Submit

November 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain score with FLACC

    (Face, Legs, Activity, Cry, and Consolability scale to assess pain in young children. Each category is scored on a 0-2 scale which results in a total score between 0 (lowest pain) and 10 (worst pain).

    30 minutes postoperative, 1 hour postoperative, 2 hour postoperative, and 6 hours postoperative

Secondary Outcomes (5)

  • The duration of the block

    immediately after the intervention, up to 24 hours postoperative

  • the Time to first postoperative rescue analgesia

    24 hours postoperative

  • Total rescue analgesia consumption

    24 hours postoperative

  • The incidence of postoperative adverse effects

    24 hours postoperative

  • Parents satisfaction score

    24 hours postoperative

Study Arms (2)

Group P

EXPERIMENTAL

In ultrasound-guided pericapsular nerve group block Group , the patient will be positioned in a supine position. The anatomical landmarks, including ilio-pubic eminence, the iliopsoas muscle and tendon, the femoral artery and vein, and the pectineus muscle, will be identified using a 9-12 MHz superficial linear transducer. A lateral to medial in-plane technique will be used to insert a 22-gauge, 50-mm needle. the needle's tip will be positioned at the musculofascial plane, located between the ilio-pubic ramus posteriorly and the psoas tendon anteriorly. Following negative aspiration to avoid intravascular injection, 0.5-1 ml of normal saline will be injected to confirm the correct needle site. A 0.5 ml/kg plain bupivacaine 0.25% will be injected.

Procedure: Pericapsular Nerves Group Block

Group C

ACTIVE COMPARATOR

the caudal epidural block will be established in the lateral decubitus position, the high-frequency linear transducer will be first placed transversely at the midline to obtain a "frog eye" sign view of the sacral cornu, the sacro-coccygeal ligament, the sacrum, and the sacral hiatus. At this position, the USG transducer will be rotated by 90° to obtain a longitudinal view. The needle will be inserted in-plane into the sacral canal and the Local anaesthetics will be injected under real-time visualization by a dose of 0.5 ml/kg plain bupivacaine 0.25%.

Procedure: Caudal Epidural Block

Interventions

USG-guided single-shot PENG in a dose of 0.5 ml/kg of 0.25% bupivacaine per side.

Also known as: PENG Block
Group P

USG-guided single-shot CEB in a dose of 0.5 mL/kg of 0.25% bupivacaine.

Also known as: CEB
Group C

Eligibility Criteria

Age1 Year - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • child aged 1- 7 years old
  • American Society of Anesthesiologists (ASA) physical status I-II
  • scheduled for elective hip surgery under general anesthesia

You may not qualify if:

  • parents/guardians refusal to participate
  • known local anesthetic drug sensitivity,
  • bleeding disorders,
  • pre-existing infection at the block site, and
  • the presence of major cardiac, renal, or hepatic disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samar Rafik Mohamed Amin

Banhā, Qalyubia Governorate, 13511, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor of anaesthesia and intensive care

Study Record Dates

First Submitted

August 13, 2024

First Posted

August 21, 2024

Study Start

August 10, 2024

Primary Completion

April 1, 2025

Study Completion

April 20, 2025

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations